Please assess the completion status of the following clinical trial:

Trial Title: PATHOS Study Pain Assessment in Thoracic Oncologic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Lobectomy/ Segmentectomy plus lymphadenectomy (systematic or sampling) for cancer (not necessarily NSCLC) performed with a standardized, three portal minimally invasive approach.~Exclusion Criteria:~* Patients who are pregnant or lactating~* Morbid obesity (BMI \> 35 )~* Inability to understand and sign the Informed consent~* Proven allergy to local anesthetic drugs as required by this protocol~* Patients under chronic analgesics or neuroleptic therapy for any reason and/ or with baseline pain score (NRS scale) of 3 or more.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Serratus Plane Loco-regional block (Type: EXPERIMENTAL): * Continuous infusion of Tramadol 200 mg or Ketorolac 60 mg~* Rescue analgesia with Morphine (0.1 mg/kg) a single time every 24 hours, and/or Tramadol 100 mg up to three times every 24 hours and/ or Ketorolac 30 mg up to three times every 24 hours~plus~Ropivacaine (30 ml, 0.3%), for Serratus Plane Block
- Standard of Care (Type: NO_INTERVENTION): * Continuous infusion of Tramadol 200 mg or Ketorolac 60 mg~* Rescue analgesia with Morphine (0.1 mg/kg) a single time every 24 hours and/or Tramadol 100 mg up to three times every 24 hours and/ or Ketorolac 30 mg up to three times every 24 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).